Answers are grounded in this paper and cite their sources.
This study identified lower persistence in the oral treatment cohort, higher costs associated with switching, and a need for safe and effective oral treatment options for patients with psoriasis to delay the switch to biologic therapy.
No takes yet. Share an insight, caveat, or question.
Thai et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: